IBDEI19N ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21534,1,2,0)
 ;;=2^90472
 ;;^UTILITY(U,$J,358.3,21534,1,3,0)
 ;;=3^Immunization Admin,Ea Addl Vacc
 ;;^UTILITY(U,$J,358.3,21535,0)
 ;;=B18.2^^87^965^26
 ;;^UTILITY(U,$J,358.3,21535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21535,1,3,0)
 ;;=3^Hepatitis C,Chr
 ;;^UTILITY(U,$J,358.3,21535,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,21535,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,21536,0)
 ;;=C44.99^^87^965^50
 ;;^UTILITY(U,$J,358.3,21536,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21536,1,3,0)
 ;;=3^Skin Cancer,Unspec
 ;;^UTILITY(U,$J,358.3,21536,1,4,0)
 ;;=4^C44.99
 ;;^UTILITY(U,$J,358.3,21536,2)
 ;;=^5001094
 ;;^UTILITY(U,$J,358.3,21537,0)
 ;;=E11.9^^87^965^15
 ;;^UTILITY(U,$J,358.3,21537,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21537,1,3,0)
 ;;=3^Diabetes Type 2
 ;;^UTILITY(U,$J,358.3,21537,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,21537,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,21538,0)
 ;;=E11.40^^87^965^16
 ;;^UTILITY(U,$J,358.3,21538,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21538,1,3,0)
 ;;=3^Diabetes Type 2 w/ Neuropathy
 ;;^UTILITY(U,$J,358.3,21538,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,21538,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,21539,0)
 ;;=E78.2^^87^965^27
 ;;^UTILITY(U,$J,358.3,21539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21539,1,3,0)
 ;;=3^Hyperlipidemia,Mixed
 ;;^UTILITY(U,$J,358.3,21539,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,21539,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,21540,0)
 ;;=E78.5^^87^965^28
 ;;^UTILITY(U,$J,358.3,21540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21540,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,21540,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,21540,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,21541,0)
 ;;=E66.3^^87^965^44
 ;;^UTILITY(U,$J,358.3,21541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21541,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,21541,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,21541,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,21542,0)
 ;;=D64.9^^87^965^3
 ;;^UTILITY(U,$J,358.3,21542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21542,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,21542,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,21542,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,21543,0)
 ;;=F17.200^^87^965^41
 ;;^UTILITY(U,$J,358.3,21543,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21543,1,3,0)
 ;;=3^Nicotine Dependence,Unspec
 ;;^UTILITY(U,$J,358.3,21543,1,4,0)
 ;;=4^F17.200
 ;;^UTILITY(U,$J,358.3,21543,2)
 ;;=^5003360
 ;;^UTILITY(U,$J,358.3,21544,0)
 ;;=F17.229^^87^965^38
 ;;^UTILITY(U,$J,358.3,21544,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21544,1,3,0)
 ;;=3^Nicotine Dependence,Chewing Tobacco
 ;;^UTILITY(U,$J,358.3,21544,1,4,0)
 ;;=4^F17.229
 ;;^UTILITY(U,$J,358.3,21544,2)
 ;;=^5003374
 ;;^UTILITY(U,$J,358.3,21545,0)
 ;;=F19.10^^87^965^53
 ;;^UTILITY(U,$J,358.3,21545,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21545,1,3,0)
 ;;=3^Substance Abuse,Unspec
 ;;^UTILITY(U,$J,358.3,21545,1,4,0)
 ;;=4^F19.10
 ;;^UTILITY(U,$J,358.3,21545,2)
 ;;=^5003416
 ;;^UTILITY(U,$J,358.3,21546,0)
 ;;=F15.10^^87^965^52
 ;;^UTILITY(U,$J,358.3,21546,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21546,1,3,0)
 ;;=3^Stimulant Abuse,Unspec
 ;;^UTILITY(U,$J,358.3,21546,1,4,0)
 ;;=4^F15.10
 ;;^UTILITY(U,$J,358.3,21546,2)
 ;;=^5003282
 ;;^UTILITY(U,$J,358.3,21547,0)
 ;;=F43.21^^87^965^2
 ;;^UTILITY(U,$J,358.3,21547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21547,1,3,0)
 ;;=3^Adjustment d/o w/ Depressed Mood
 ;;^UTILITY(U,$J,358.3,21547,1,4,0)
 ;;=4^F43.21
 ;;^UTILITY(U,$J,358.3,21547,2)
 ;;=^331948
 ;;^UTILITY(U,$J,358.3,21548,0)
 ;;=G43.909^^87^965^37
